Endocrine Today Current Issue

The following articles appeared in the print edition of Endocrine Today.

Table of Contents

• Role of sugar in obesity, diabetes still up for debate
• Experts evaluate relevance of disputed data on HT, breast cancer
• New drug application for SGLT2, empagliflozin, submitted to FDA
• FDA to investigate data on incretin mimetics for pancreatitis, cancer risk
• FDA panel rejects continued marketing of calcitonin salmon for osteoporosis
• FDA approves new packet option for AndroGel 1.62%
• Foreign body in thyroid of 58-year-old male Donny L.F. Chang, MD, PhD; Stephanie L. Lee, MD, PhD, ECNU
• ACA could increase demand for primary care, exceed supply by 10%
• Behavioral program led to weight loss in patients with mental illness
• Diabetes prevention programs produced long-term benefits
• Endocrine Society advocates for improved estrogen testing methods
• Maps reveal increased prevalence of obesity in Canada
• Obesity linked to risk for molecular subtype of colorectal cancer
• Oral estrogen HT increased risk for cholecystectomy
• Reduced cortisol metabolism contributed to abnormal blood hormone levels
• Researchers assess 48-hour effects of cinacalcet in patients with secondary hyperparathyroidism
• Researchers examine relationship between PCOS, insulin-mediated glucose uptake
• Sitting less may be more effective approach to reduce diabetes risk
• Type 1 diabetes affects relationships for patients, their partners
• Ultrasound predicted biologic behavior of papillary thyroid cancer
• Walnut consumption lowered risk for type 2 diabetes in women
• Expert addresses relevant relationship between thyroid, CVD
• Financial incentives motivated weight loss
• Gastric banding led to improvements in HDL, particle size after 5 years
• Jackson Heart Study: Remnant lipoprotein cholesterol predicted MI in black patients
• Researchers associate fluctuation in lipids with seasonal changes
• TERISA: Ranolazine reduced angina in patients with diabetes
• Weight gain early in life led to cardiovascular disease
• How common herbal supplements affect diabetes James R. Taylor, PharmD, CDE